$AVEO i see 1 of 3 possible scenarios playing out: 1) fda rejects NDA until June data is released, at which SP drops another 50% 2) FDA accepts NDA with the HR contingency of <1, SP pops 100% to 5-6 3) FDA accepts NDA and issues fast track with the HR contingency, SP pops 400% above 10 The reward is far greater than the risk especially at these levels
  • 10
  • 12